Accueil › Maladie de Crohn › Pennsylvanie
Essais cliniques pour Maladie de Crohn dans Pennsylvanie
23 études pour Maladie de Crohn recherchent des participants dans Pennsylvanie.
Villes dans Pennsylvanie
Texte officiel de l'étude (anglais)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Penn State University Milton S. Hershey Medical Center ( Site 5102), Hershey
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
- Frontier Clinical Research, LLC ( Site 5098), Uniontown
Recrutement en coursPhase 3
Âges de 16 à 80 · Tous sexes · Mis à jour le 2 oct. 2026 · NCT06430801A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
Recrutement en coursPhase 3
Âges de 2 à 17 · Tous sexes · Mis à jour le 25 sept. 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
Recrutement en coursPhase 2
Âges de 18 à 75 · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Frontier Clinical Research, Uniontown
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Susquehanna Research Group, Harrisburg
- Penn State Milton S Hershey Medical Ctr, Hershey
- University of Pennsylvania, Philadelphia
- et 1 autres
Recrutement en coursPhase 2/3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07196722Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Recrutement en coursPhase 3
Âges de 18 à 70 · Tous sexes · Mis à jour le 24 sept. 2026 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 23 sept. 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Penn State Milton S. Hershey Medical Center-Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
Recrutement en coursPhase 3
Âges de 16 à 80 · Tous sexes · Mis à jour le 23 sept. 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
Recrutement en coursPhase 3
Âges de 16 à 80 · Tous sexes · Mis à jour le 23 sept. 2026 · NCT07184944A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
Recrutement en coursPhase 3
Âges de 2 à 19 · Tous sexes · Mis à jour le 22 sept. 2026 · NCT04844606A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Allegheny Health Network, Wexford
Recrutement en coursPhase 4
Âges de 18 à 70 · Tous sexes · Mis à jour le 9 sept. 2026 · NCT06045754A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
Recrutement en coursPhase 3
Âges de 2 à 17 · Tous sexes · Mis à jour le 24 août 2026 · NCT05509777Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Recrutement en coursPhase 3
Âges de 2 à 17 · Tous sexes · Mis à jour le 24 juin 2026 · NCT06332534A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
Recrutement en coursPhase 3
Âges de 2 à 17 · Tous sexes · Mis à jour le 22 juin 2026 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Recrutement en coursPhase 4
Âges de 6 à 17 · Tous sexes · Mis à jour le 27 mai 2026 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Children's Hospital of Pittsburgh, Pittsburgh
Recrutement en coursPhase 3
Âges de 2 à 17 · Tous sexes · Mis à jour le 5 mai 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Susquehanna Research Group, LLC, Harrisburg
- UPMC, Pittsburgh
- Frontier Clinical Research, LLC, Uniontown
Recrutement en coursPhase 2
Âges de 18 à 75 · Tous sexes · Mis à jour le 27 avr. 2026 · NCT06456593COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
- University of Pittsburgh Medical Center, Children's Hospital, Pittsburgh
Recrutement en coursÉtude observationnelle
Âges de 1 à 18 · Tous sexes · Mis à jour le 17 avr. 2026 · NCT07198113A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400009, Harrisburg
Recrutement en coursPhase 2
Âges de 18 à 75 · Tous sexes · Mis à jour le 27 mars 2026 · NCT06958536Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Recrutement en coursÉtude observationnelle
2 Months – 60 Years · Tous sexes · Mis à jour le 13 janv. 2026 · NCT04528355Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Recrutement en coursPhase 2
2 Months – 55 Years · Tous sexes · Mis à jour le 15 déc. 2025 · NCT01962415Autologous Stem Cell Transplantation for Crohn's Disease
- UPMC Prebyterian- Adult Gastroenterology, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh
Recrutement en coursPhase 1/2
Âges de 10 à 60 · Tous sexes · Mis à jour le 15 déc. 2025 · NCT00692939Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
- Children's Hospital of Philadelphia, Philadelphia
Recrutement en cours
Âges de 8 à 21 · Tous sexes · Mis à jour le 12 juin 2025 · NCT06216899Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.